Department of Endocrinology, Ghent University Hospital, C. Heymanslaan 10, 9000, Ghent, Belgium.
Center for Sexology and Gender, Ghent University Hospital, C. Heymanslaan 10, 9000, Ghent, Belgium.
Int J Impot Res. 2020 Nov;33(7):694-702. doi: 10.1038/s41443-020-00402-7. Epub 2021 Jan 22.
Transgender people and their next-of-kin may request information on sexual orientation and preferred partners during hormonal affirming process. Although previous research on sexual orientation in transgender people is extensive, this literature may already be outdated and/or the methodology of studies assessing sexual orientation may fall short. This prospective cohort study was part of the European Network for the Investigation of Gender Incongruence (ENIGI). Gender role and preferred partner in sexual fantasies, sexual orientation and gender of current sexual partner were assessed at baseline (initiation of HT) and every follow-up visit. Data from 469 transgender women (TW) and 433 transgender men (TM) were analyzed cross-sectionally and prospectively. At baseline, more than half reported having no partner (35% of TW, 47% of TM). After 12 months, more than half reported having a partner (59% of TW, 56% of TM), with no changes between one and three years of HT. The majority of TM preferred a female partner, TW preferred male and female partners. The sexual identity of their partner matched their sexual orientation in >80%. Sexual orientation did not change over time. We did not observe associations with serum levels of sex steroids or gender-affirming surgery (chest or genital surgery). Sexual orientation did not change during hormonal transition and was not associated with sex steroids or surgery. Also, preferences matched the partner's sexual identity. We do not assume that changing serum levels of sex steroids is directly associated with changes in partner choice. The number of people with a current partner increased, possibly due to the indirect effects of gender-affirming care.
跨性别者及其近亲在进行激素治疗时可能会要求了解其性取向和偏好的伴侣信息。虽然之前有很多关于跨性别者性取向的研究，但这些文献可能已经过时，或者评估性取向的研究方法可能存在不足。这项前瞻性队列研究是欧洲性别不一致研究网络（ENIGI）的一部分。在基线（开始进行激素治疗时）和每次随访时，评估了性别角色和性幻想中的偏好伴侣、性取向以及当前性伴侣的性别。对 469 名跨性别女性（TW）和 433 名跨性别男性（TM）的数据进行了横断面和前瞻性分析。基线时，超过一半的人报告没有伴侣（35%的 TW，47%的 TM）。12 个月后，超过一半的人报告有伴侣（59%的 TW，56%的 TM），在 HT1 到 3 年之间没有变化。大多数 TM 更喜欢女性伴侣，TW 则更喜欢男性和女性伴侣。他们伴侣的性身份与其性取向相匹配的比例超过 80%。性取向在随访期间没有改变。我们没有观察到性取向与血清性激素水平或性别肯定手术（胸部或生殖器手术）之间存在关联。性取向在激素过渡期间没有改变，也与性激素或手术无关。此外，偏好与伴侣的性身份相匹配。我们不认为血清性激素水平的变化与伴侣选择的变化直接相关。目前有伴侣的人数增加，可能是由于性别肯定护理的间接影响。
